Cardinal Health Stock Surges on Earnings Beat and Solaris Deal

Cardinal Health (CAH) Valuation Check After Earnings Beat Guidance Uplift And Solaris Health Acquisition

Simply Wall St - Stock & Sector Analysis Made Simple2026.03.13Updated 23d ago

Why Cardinal Health’s latest quarter matters for investors Cardinal Health (CAH) recently reported quarterly earnings and guidance that came in ahead of consensus, paired with acquisitions like Solaris Health, new product launches, and a maintained dividend, drawing fresh attention to the stock. See our latest analysis for Cardinal Health. At a share price of US$219.09, Cardinal Health has seen momentum build, with a 10.55% 90 day share price return and a very strong 1 year total shareholder...

AI SummaryPowered by AI

Cardinal Health (CAH) exceeded earnings expectations and raised guidance while announcing the Solaris Health acquisition, driving a 10.55% surge in 90-day returns. The healthcare distributor maintained its dividend and launched new products, signaling strong operational momentum. At $219.09 per share, investors are reassessing the stock's valuation metrics.

Key topics:cardinal health cah stock solaris health acquisition earnings beat healthcare distributor

Original Article

Read full article on Simply Wall St - Stock & Sector Analysis Made Simple